We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
-11.79%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$29.8M
Cap. Flow
+$9.22M
Cap. Flow %
4.06%
Top 10 Hldgs %
39.83%
Holding
81
New
31
Increased
12
Reduced
7
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$10.7M
2
AZN icon
AstraZeneca
AZN
+$8.94M
3
EHC icon
Encompass Health
EHC
+$8.33M
4
CTLT
CATALENT, INC.
CTLT
+$8.19M
5
DHR icon
Danaher
DHR
+$7.6M

Top Sells

Rank Stock Value
1
A icon
Agilent Technologies
A
+$14.5M
2
DXCM icon
DexCom
DXCM
+$13.1M
3
AMED
Amedisys
AMED
+$10.8M
4
SNY icon
Sanofi
SNY
+$9.54M
5
VAR
Varian Medical Systems, Inc.
VAR
+$8.52M

Sector Composition

Rank Sector Weight
1 Healthcare 88.54%
2 Energy 3.09%
3 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZYME icon
76
Zymeworks
ZYME
$1.84B
– –
-65,000
Closed -$2.96M
SWAV
77
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-90,000
Closed -$3.95M
SGEN
78
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-30,000
Closed -$3.43M
NUVA
79
DELISTED
NuVasive, Inc.
NUVA
– –
-80,000
Closed -$6.19M
VAR
80
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-60,000
Closed -$8.52M
AIMT
81
DELISTED
Aimmune Therapeutics
AIMT
– –
-50,000
Closed -$1.67M
1 2 3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Integral Health Asset Management held 81 positions worth $227M, down 12% from $257M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Integral Health Asset Management deployed $9.22M of net new capital in Q1 2020, opening 31 new positions and adding to 12 existing holdings. Its largest new stake was Merck: 136,240 shares worth $10M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 93% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was Humana, an estimated $6.07M trimmed.

  • Integral Health Asset Management's largest Q1 2020 buy was Merck: 136,240 shares worth $10M.
  • Integral Health Asset Management added most to ChemoCentryx, Inc. in Q1 2020, an estimated $5.94M increase.
  • Integral Health Asset Management's biggest Q1 2020 reduction was Humana, cutting an estimated $6.07M.
  • Integral Health Asset Management fully exited Agilent Technologies in Q1 2020, selling an estimated $14.5M.
  • Integral Health Asset Management's ten largest holdings make up 40% of its $227M portfolio in Q1 2020.
  • Integral Health Asset Management opened 31 new positions and closed 30 in Q1 2020.
  • Integral Health Asset Management's portfolio value fell 12% quarter-over-quarter to $227M.

Based on Integral Health Asset Management's 13F filing for Q1 2020, filed 15 May 2020.